Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Scott M. Lindhorst"'
Autor:
C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, Igor J Barani, Steve Braunstein, Joseph A Bovi, John F de Groot, Anthony C Whitton, Scott M Lindhorst, Nimisha Deb, Dennis C Shrieve, Hui-Kuo Shu, Beatrice Bloom, Mitchell Machtay, Mark V Mishra, Clifford G Robinson, Minhee Won, Minesh P Mehta
Publikováno v:
Neuro Oncol
Background Three- and five-year progression-free survival (PFS) for low-risk meningioma managed with surgery and observation reportedly exceeds 90%. Herewith we summarize outcomes for low-risk meningioma patients enrolled on NRG/RTOG 0539. Methods Th
Autor:
David Cachia, Ramin Eskandari, Daniel G. McDonald, Libby Kosnik Infinger, William A. Vandergrift, Abhay K. Varma, Sunil J. Patel, Alicia M. Zukas, Scott M. Lindhorst, ARABINDA DAS
Publikováno v:
Wednesday, April 26.
Autor:
Christina I. Tsien, Stephanie L. Pugh, Adam P. Dicker, Jeffrey J. Raizer, Martha M. Matuszak, Enrico C. Lallana, Jiayi Huang, Ozer Algan, Nimisha Deb, Lorraine Portelance, John L. Villano, John T. Hamm, Kevin S. Oh, Arif N. Ali, Michelle M. Kim, Scott M. Lindhorst, Minesh P. Mehta
PURPOSE To assess whether reirradiation (re-RT) and concurrent bevacizumab (BEV) improve overall survival (OS) and/or progression-free survival (PFS), compared with BEV alone in recurrent glioblastoma (GBM). The primary objective was OS, and secondar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4c03b0f137d718334db45ae38b7cb4
https://www.zora.uzh.ch/id/eprint/228975/
https://www.zora.uzh.ch/id/eprint/228975/
Autor:
Linda M. Liau, Keyoumars Ashkan, Steven Brem, Jian L. Campian, John E. Trusheim, Fabio M. Iwamoto, David D. Tran, George Ansstas, Charles S. Cobbs, Jason A. Heth, Michael E. Salacz, Stacy D’Andre, Robert D. Aiken, Yaron A. Moshel, Joo Y. Nam, Clement P. Pillainayagam, Stephanie A. Wagner, Kevin A. Walter, Rekha Chaudhary, Samuel A. Goldlust, Ian Y. Lee, Daniela A. Bota, Heinrich Elinzano, Jai Grewal, Kevin Lillehei, Tom Mikkelsen, Tobias Walbert, Steven Abram, Andrew J. Brenner, Matthew G. Ewend, Simon Khagi, Darren S. Lovick, Jana Portnow, Lyndon Kim, William G. Loudon, Nina L. Martinez, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott M. Lindhorst, Jose Lutzky, Hans-Jörg Meisel, Minou Nadji-Ohl, Lhagva Sanchin, Andrew Sloan, Lynne P. Taylor, Julian K. Wu, Erin M. Dunbar, Arnold B. Etame, Santosh Kesari, David Mathieu, David E. Piccioni, David S. Baskin, Michel Lacroix, Sven-Axel May, Pamela Z. New, Timothy J. Pluard, Steven A. Toms, Victor Tse, Scott Peak, John L. Villano, James D. Battiste, Paul J. Mulholland, Michael L. Pearlman, Kevin Petrecca, Michael Schulder, Robert M. Prins, Alton L. Boynton, Marnix L. Bosch
Publikováno v:
JAMA oncology.
ImportanceGlioblastoma is the most lethal primary brain cancer. Clinical outcomes for glioblastoma remain poor, and new treatments are needed.ObjectiveTo investigate whether adding autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) to st
Autor:
Arabinda Das, Arunprasad Gunasekaran, Heather R. Stephens, Joseph Mark, Scott M. Lindhorst, David Cachia, Sunil J. Patel, Bruce M. Frankel
Publikováno v:
World neurosurgery. 161
Glioblastoma (GB) is an aggressive tumor showing extensive intertumoral and intratumoral heterogeneity. Several possible reasons contribute to the historical inability to develop effective therapeutic strategies for treatment of GB. One such challeng
Autor:
Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian Campian, John Trusheim, Fabio Iwamoto, David Tran, George Anstass, Charles Cobbs, Jason Heth, Michael Salacz, Stacy D'Andre, Robert Aiken, Yaron Moshel, JooYeon Nam, Clement Pillainayagam, Stephanie Wagner, Kevin Walter, Rekha Chaudary, Samuel Goldlust, Ian Lee, Daniela Bota, Heinrich Elinzano, Jai Grewal, Kevin Lillehei, Tom Mikkelsen, Tobias Walbert, Steve Abram, Andrew Brenner, Matthew Ewend, Simon Khagi, Darren Lovick, Jana Portnow, Lyndon Kim, William Loudon, Nina Martinez, Reid Thompson, David Avigan, Karen Fink, Francois Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott M Lindhorst, Jose Lutzky, Hans-Joerg Meisel, Minou Nadji-Ohl, Lhagva Sanchin, Andrew Sloan, Marnix Bosch
Publikováno v:
Neuro-Oncology. 24:vii66-vii66
BACKGROUND Standard of care (SOC) and patient survival in glioblastoma have changed little in the past 17 years. We evaluated in a phase 3 trial whether adding an autologous tumor lysate-loaded dendritic cell vaccine (murcidencel) to SOC extends surv
Autor:
Arabinda Das, Daniel G McDonald, Milad Yazdani, Connor Stephenson, Shikhar Mehrotra, Cynthia A Welsh, Libby Kosnik Infinger, William A Vandergrift, Abhay K Varma, Sunil J Patel, Pierre Giglio, Alicia Zukas, David Cachia, Scott M Lindhorst
Publikováno v:
Neuro-Oncology. 24:vii230-vii230
Atypical and anaplastic meningiomas (WHO Grade 2 and WHO Grade 3 respectively) represent a subgroup of meningiomas that tend to have higher rates of recurrence with associated’s higher morbidity and mortality than the more common WHO Grade 1 mening
Autor:
Arabinda Das, Arunprasad Gunasekaran, Heather R Stephens, Penny Sekerak, Joseph Mark, Daniel G McDonald, Milad Yazdani, Connor Stephenson, Cynthia A Welsh, Libby Kosnik Infinger, William A Vandergrift, Shikhar Mehrotra, Abhay K Varma, Pierre Giglio, Sunil J Patel, Bruce M Frankel, Alicia Zukas, David Cachia, Scott M Lindhorst
Publikováno v:
Neuro-Oncology. 24:vii234-vii234
Glioblastoma (GB) is an aggressive tumor showing extensive intertumoral and intratumoral heterogeneity. While preserving as much surrounding normal brain tissue as possible, neurosurgeons must aim to harvest maximal tumor tissue from a variety of tum
Autor:
Connor Stephenson, Daniel G McDonald, Milad Yazdani, Shikhar Mehrotra, Cynthia A Welsh, Libby Kosnik Infinger, William A Vandergrift, Abhay K Varma, Sunil J Patel, Pierre Giglio, Alicia Zukas, David Cachia, Scott M Lindhorst, Arabinda Das
Publikováno v:
Neuro-Oncology. 24:vii183-vii183
Glioblastoma (GB) patients often present with either radiation-induced necrosis (RN) or develop tumor recurrence (TR). Radiologically, differentiating between these two disease states is particularly difficult, especially utilizing traditional MRI te
Autor:
Philip, Lee, Ben, Murphy, Rickey, Miller, Vivek, Menon, Naren L, Banik, Pierre, Giglio, Scott M, Lindhorst, Abhay K, Varma, William A, Vandergrift, Sunil J, Patel, Arabinda, Das
Publikováno v:
Anticancer research. 35(2)
Glioblastoma is the most common and deadliest of malignant primary brain tumors (Grade IV astrocytoma) in adults. Current standard treatments have been improving but patient prognosis still remains unacceptably devastating. Glioblastoma recurrence is